- Report
- June 2025
- 400 Pages
Global
From €4410EUR$4,949USD£3,825GBP
- Report
- April 2025
- 200 Pages
Global
From €7084EUR$7,950USD£6,144GBP
- Drug Pipelines
- April 2025
- 90 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1114EUR$1,250USD£966GBP
- Report
- January 2025
- 880 Pages
Global
From €7084EUR$7,950USD£6,144GBP
- Report
- April 2025
- 185 Pages
Global
From €3408EUR$3,825USD£2,956GBP
€4010EUR$4,500USD£3,478GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2673EUR$3,000USD£2,319GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,159GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,159GBP
- Drug Pipelines
- April 2025
- 40 Pages
Global
From €1114EUR$1,250USD£966GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2673EUR$3,000USD£2,319GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2485EUR$2,789USD£2,156GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2485EUR$2,789USD£2,156GBP
- Report
- August 2024
- 150 Pages
Global
From €2485EUR$2,789USD£2,156GBP
- Report
- March 2025
- 115 Pages
Global
From €3500EUR$4,208USD£3,142GBP
- Report
- January 2025
- 93 Pages
Global
From €3500EUR$4,208USD£3,142GBP
- Report
- November 2024
- 301 Pages
Global
From €4010EUR$4,500USD£3,478GBP
- Report
- July 2025
Global
From €400EUR$481USD£359GBP
- Report
- August 2024
- 660 Pages
Brazil
From €2941EUR$3,300USD£2,550GBP

Docetaxel is a chemotherapy drug used in the treatment of various types of cancer, including breast, ovarian, and non-small cell lung cancer. It is a semi-synthetic derivative of a natural substance found in the bark of the European yew tree. Docetaxel works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is usually administered intravenously, and is often used in combination with other drugs.
Docetaxel is a widely used oncology drug, and is often prescribed as a first-line treatment for certain types of cancer. It is also used in the treatment of advanced or metastatic cancer, and is sometimes used in combination with other drugs to improve the effectiveness of treatment.
Some companies in the Docetaxel market include Bristol-Myers Squibb, Pfizer, and Sanofi. Show Less Read more